tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
Holding BCLI?
Track your performance easily

Brainstorm Cell Therapeutics (BCLI) Income Statement

536 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q2 2024), Brainstorm Cell Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Brainstorm Cell Therapeutics's net income was $-2.54M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 16.06M$ 21.44M$ 24.82M$ 24.54M$ 31.68M$ 23.00M
Operating Income
$ -16.06M$ -21.44M$ -24.82M$ -24.54M$ -31.68M$ -23.00M
Net Non Operating Interest Income Expense
--$ -545.00K---
Other Income Expense
$ 529.00K$ -4.53M----
Pretax Income
$ -15.64M$ -21.44M$ -24.28M$ -24.54M$ -31.68M$ -23.00M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -16.33M$ -17.19M$ -24.28M$ -24.46M$ -31.56M$ -23.25M
Basic EPS
$ -0.36$ -0.40$ -0.66$ -0.68$ -1.07-
Diluted EPS
$ -0.36$ -0.40$ -0.66$ -0.68$ -1.07$ -1.06
Basic Average Shares
$ 212.39M$ 43.08M$ 36.51M$ 36.18M$ 29.85M$ 21.91M
Diluted Average Shares
$ 212.39M$ 43.08M$ 36.51M$ 36.18M$ 29.85M$ 21.94M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 16.06M$ 21.44M$ 24.82M$ 24.54M$ 31.68M$ 23.00M
Net Income From Continuing And Discontinued Operation
$ -16.33M$ -17.19M$ -24.28M$ -24.46M$ -31.81M$ -23.25M
Normalized Income
$ -4.99M-----
Interest Expense
------
EBIT
$ -15.49M$ -21.44M$ -24.82M$ -24.54M$ -31.68M$ -23.00M
EBITDA
$ -15.23M$ -21.17M$ -24.54M$ -24.28M$ -31.46M$ -22.84M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis